HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Medicines And Cosmetics Industries Set To Pay At Least 80% Of Wastewater Treatment Costs

Executive Summary

The EU's revised Urban Wastewater Treatment Directive is one step closer to implementation thanks to provisional agreement between the European Parliament and Council. In line with the “polluter pays” principle, producers of pharmaceuticals and cosmetics should contribute at least 80% towards the costs of removing micropollutants from wastewater through quaternary treatment, the legislative bodies agree. 

You may also be interested in...



ENVI: Prescription Requirement Only With Evidence Of Antimicrobial Resistance

The EU Parliament's Environment, Public Health and Food Safety committee proposes a “compromise amendment” to the new pharmaceutical directive that would include only antimicrobials for which there is an “identified risk of antimicrobial resistance” to the prescription requirement. 

EU Cosmetics, Pharma Industries Expected To Pick Up Tab For Micropollutants Under Proposed UWWTD Recast

Cosmetics Europe says the European Commission’s proposed recast of the Urban Wastewater Treatment Directive places responsibility for micro-pollutants in urban wastewater squarely on the cosmetics and pharmaceuticals industries, ignoring other sources. The proposal would require Member States to provide for extended producer responsibility (EPR) systems to fund upgrades to wastewater treatment plants and administrative costs.

European Commission Lays Down ‘Zero Pollution’ Gauntlet To Consumer Health Industry

Europe's consumer health industry is faced with proliferating regulations under the EU's Green Deal policy program. Proposed revisions to the Urban Wastewater Treatment Directive, for example, expect pharmaceutical and cosmetics manufacturers to pay for the removal of micro-pollutants that are mostly flushed into the wastewater system by consumers. While the European Commission says it is “sympathetic” to industry's concerns, such as those raised at the AESGP Annual Meeting and in recent publications, its director for zero pollution and green cities, Veronica Manfredi, stressed that “there are no excuses, there can be no business as usual” given the urgency of the situation. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154412

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel